Literature DB >> 10754312

Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.

P T Mattsson1, I Lappalainen, C M Bäckesjö, E Brockmann, S Laurén, M Vihinen, C I Smith.   

Abstract

Src homology 2 (SH2) domains recognize phosphotyrosine (pY)-containing sequences and thereby mediate their association to ligands. Bruton's tyrosine kinase (Btk) is a cytoplasmic protein tyrosine kinase, in which mutations cause a hereditary immunodeficiency disease, X-linked agammaglobulinemia (XLA). Mutations have been found in all Btk domains, including SH2. We have analyzed the structural and functional effects of six disease-related amino acid substitutions in the SH2 domain: G302E, R307G, Y334S, L358F, Y361C, and H362Q. Also, we present a novel Btk SH2 missense mutation, H362R, leading to classical XLA. Based on circular dichroism analysis, the conformation of five of the XLA mutants studied differs from the native Btk SH2 domain, while mutant R307G is structurally identical. The binding of XLA mutation-containing SH2 domains to pY-Sepharose was reduced, varying between 1 and 13% of that for the native SH2 domain. The solubility of all the mutated proteins was remarkably reduced. SH2 domain mutations were divided into three categories: 1) Functional mutations, which affect residues presumably participating directly in pY binding (R307G); 2) structural mutations that, via conformational change, not only impair pY binding, but severely derange the structure of the SH2 domain and possibly interfere with the overall conformation of the Btk molecule (G302E, Y334S, L358F, and H362Q); and 3) structural-functional mutations, which contain features from both categories above (Y361C).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754312     DOI: 10.4049/jimmunol.164.8.4170

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases.

Authors:  B Al-Lazikani; F B Sheinerman; B Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Types and effects of protein variations.

Authors:  Mauno Vihinen
Journal:  Hum Genet       Date:  2015-01-24       Impact factor: 4.132

Review 3.  Targeting B cells in treatment of autoimmunity.

Authors:  S Elizabeth Franks; Andrew Getahun; P Mark Hogarth; John C Cambier
Journal:  Curr Opin Immunol       Date:  2016-10-05       Impact factor: 7.486

4.  X-Linked agammaglobulinemia in a child with Klinefelter's syndrome.

Authors:  Alexis-Virgil Cochino; Ales Janda; Barbora Ravcukova; Vasilica Plaiasu; Diana Ochiana; Ioan Gherghina; Tomas Freiberger
Journal:  J Clin Immunol       Date:  2014-01-30       Impact factor: 8.317

5.  Variation Ontology for annotation of variation effects and mechanisms.

Authors:  Mauno Vihinen
Journal:  Genome Res       Date:  2013-10-25       Impact factor: 9.043

6.  Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.

Authors:  Daniel P Duarte; Allan J Lamontanara; Giuseppina La Sala; Sukyo Jeong; Yoo-Kyoung Sohn; Alejandro Panjkovich; Sandrine Georgeon; Tim Kükenshöner; Maria J Marcaida; Florence Pojer; Marco De Vivo; Dmitri Svergun; Hak-Sung Kim; Matteo Dal Peraro; Oliver Hantschel
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

Review 7.  Systematics for types and effects of DNA variations.

Authors:  Mauno Vihinen
Journal:  BMC Genomics       Date:  2018-12-28       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.